PET/MRI reveals more than just nerve impingement causing sciatica

Radiology and orthopedics researchers at Stanford have shown the prowess of nuclear imaging for identifying the specific source(s) of pain and reduced mobility in patients with chronic sciatica, a common low-back condition notorious for evading such pinpointing.

The Journal of Nuclear Medicine published the team’s findings online Nov. 2.

Senior study author Sandip Biswal, MD, and colleagues performed PET/MRI using the radiotracer fluorodeoxyglucose (18F-FDG) on nine symptomatic patients and five healthy volunteers.

In all nine patients, the researchers recorded significantly increased FDG uptake in detected lesions correlating with pain and related symptoms.

Further, along with finding FDG-avid lesions in impinged nerves of the lumbar spine—no surprise—they also observed uptake activity that associated with non-spinal causes. These included facet-joint degeneration and pars defect, along with a presumed scar neuroma.

“The feasibility of 18F-FDG PET/MRI for diagnosing pain generators in chronic sciatica has been demonstrated, revealing various possible etiologies,” Biswal et al. report.

Sciatica, which frequently radiates pain and reduced mobility into the buttocks and legs, can be painful to the point of debilitating. Without surgery or another intervention, serious cases can lead to paralysis of the lower extremities and urinary and/or fecal incontinence.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.